Condition

Mycobacterium Infections, Atypical (2)

Healthy (1)

Overall Status

Completed (2)

Sign in for free

Phase

phase 2 (1)

Sponsor

Mylan Inc. (1)

National Institute of Allergy and Infectious Diseases (NIAID) (1)

Collaborator

Taisho Pharmaceutical Co., Ltd. (1)

Intervention

interferon gamma (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Industry (1)

NIH (1)

Study Type

Interventional (1)

Observational (1)

mycobacterium infections, atypical

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Clarith/Klaricid in Non-tuberculous Mycobacterial Pulmonary

Completed

Mycobacterium Infections, Atypical

Aichi, Japan
+58 more

Mar 18, 2022

Healthy, Mycobacterium Infections, Atypical Trial run by the NIAID (interferon gamma)

Completed

Healthy
Mycobacterium Infections, Atypical

interferon gamma

Bethesda, Maryland

National Institute of Allergy and Infectious Diseases (NIAID)

Mar 3, 2008